Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

[Major hypoglycemic ingredients of Panax notoginseng saponins for treating diabetes].

Zhong ZD, Wang CM, Wang W, Shen L, Chen ZH.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 Mar;45(2):235-9. Chinese.

PMID:
24749347
2.

Anti-diabetic effects of Panax notoginseng saponins and its major anti-hyperglycemic components.

Yang CY, Wang J, Zhao Y, Shen L, Jiang X, Xie ZG, Liang N, Zhang L, Chen ZH.

J Ethnopharmacol. 2010 Jul 20;130(2):231-6. doi: 10.1016/j.jep.2010.04.039. Epub 2010 May 8.

PMID:
20435129
3.

[Effects of Panax notoginseng saponins on anti-hyperglycemic, anti-obese and prevention from kidney pathological changes in KK-Ay mice].

Yang CY, Xie ZG, Cheng WB, Jiang X, Chen ZH.

Zhong Yao Cai. 2009 Oct;32(10):1571-6. Chinese.

PMID:
20112724
4.

Saponins isolated from the root of Panax notoginseng showed significant anti-diabetic effects in KK-Ay mice.

Chen ZH, Li J, Liu J, Zhao Y, Zhang P, Zhang MX, Zhang L.

Am J Chin Med. 2008;36(5):939-51.

PMID:
19051359
5.

Inhibiting adhesion events by Panax notoginseng saponins and Ginsenoside Rb1 protecting arteries via activation of Nrf2 and suppression of p38 - VCAM-1 signal pathway.

Fan J, Liu D, He C, Li X, He F.

J Ethnopharmacol. 2016 Nov 4;192:423-430. doi: 10.1016/j.jep.2016.09.022. Epub 2016 Sep 13.

PMID:
27620662
6.

Panax notoginseng saponins provide neuroprotection by regulating NgR1/RhoA/ROCK2 pathway expression, in vitro and in vivo.

Shi X, Yu W, Yang T, Liu W, Zhao Y, Sun Y, Chai L, Gao Y, Dong B, Zhu L.

J Ethnopharmacol. 2016 Aug 22;190:301-12. doi: 10.1016/j.jep.2016.06.017. Epub 2016 Jun 8.

PMID:
27288754
7.

Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.

Huang XP, Ding H, Lu JD, Tang YH, Deng BX, Deng CQ.

Am J Chin Med. 2015;43(7):1419-38. doi: 10.1142/S0192415X15500809. Epub 2015 Oct 18.

PMID:
26477799
8.

[Contents of total anthocyanins and total saponins as well as composition of saponin monomers of Purple and Green Notoginseng Radix et Rhizoma].

Zhao CL, Yang SC, Chen ZJ, Shen Y, Wei FG, Wang W, Long TJ.

Zhong Yao Cai. 2014 Oct;37(10):1749-53. Chinese.

PMID:
25895378
9.

Brain distribution pharmacokinetics and integrated pharmacokinetics of Panax Notoginsenoside R1, Ginsenosides Rg1, Rb1, Re and Rd in rats after intranasal administration of Panax Notoginseng Saponins assessed by UPLC/MS/MS.

Guo Q, Li P, Wang Z, Cheng Y, Wu H, Yang B, Du S, Lu Y.

J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Oct 15;969:264-71. doi: 10.1016/j.jchromb.2014.08.034. Epub 2014 Sep 3.

PMID:
25203723
10.

Anti-diabetic potential of Panax notoginseng saponins (PNS): a review.

Uzayisenga R, Ayeka PA, Wang Y.

Phytother Res. 2014 Apr;28(4):510-6. doi: 10.1002/ptr.5026. Epub 2013 Jul 11. Review.

PMID:
23846979
11.
12.

Endothelium-dependent vasodilation effects of Panax notoginseng and its main components are mediated by nitric oxide and cyclooxygenase pathways.

Wang Y, Ren Y, Xing L, Dai X, Liu S, Yu B, Wang Y.

Exp Ther Med. 2016 Dec;12(6):3998-4006. doi: 10.3892/etm.2016.3890. Epub 2016 Nov 9.

14.
16.

[In vitro balanced sustained-release of Panax notoginseng saponins controlled with various matrix materials].

Zhou X, Fu CM, He Y, Zhang JM, Liu HY.

Yao Xue Xue Bao. 2010 Apr;45(4):505-9. Chinese.

PMID:
21355219
17.

Effect of aspirin on the pharmacokinetics and absorption of panax notoginseng saponins.

Tian Z, Pang H, Zhang Q, Du S, Lu Y, Zhang L, Bai J, Li P, Li D, Zhao M, Chen X.

J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Feb 1;1074-1075:25-33. doi: 10.1016/j.jchromb.2017.12.033. Epub 2018 Jan 2.

PMID:
29329092
18.

Panax notoginseng saponins protect kidney from diabetes by up-regulating silent information regulator 1 and activating antioxidant proteins in rats.

Du YG, Wang LP, Qian JW, Zhang KN, Chai KF.

Chin J Integr Med. 2016 Dec;22(12):910-917. Epub 2015 Dec 28.

PMID:
26712211
19.

[In vivo distribution and pharmacokinetics of multiple effective components contained in Panax notoginseng saponins after intratympanic administration].

Chen G, Mu L, Zhang X, Hou S, Nan H.

Zhongguo Zhong Yao Za Zhi. 2011 Jul;36(13):1815-20. Chinese.

PMID:
22032151
20.

[Optimization of Formulation of Panax notoginseng Saponins Transfersomes].

Chang C, Chen SS, Yang HT, Zheng HS.

Zhong Yao Cai. 2015 Dec;38(12):2602-5. Chinese.

PMID:
27352543

Supplemental Content

Support Center